The Indian Council of Medical Research (ICMR) has disassociated itself from a study on the Covaxin vaccine, citing serious methodological flaws and an erroneous acknowledgment of ICMR's support.

The Serum Institute of India (SII), which partnered with AstraZeneca to manufacture Covishield, has issued a statement clarifying its position.